Clinical Trial Update: Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the use of Forteo (teriparatide) in posterolateral lumbar spine fusion has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Lumbar Scoliosis
• Lumbar Spondylolisthesis
• Lumbar Spondylosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Shane Burch | Conditions: Lumbar Spondylosis, Lumbar Spondylolisthesis | Phase 4 | Status: COMPLETED | Results posted: 2021-02-17